(GAIN) Gladstone Investment - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3765461070
GAIN: Debt Securities, Equity Investments, Loans, Notes, Warrants
Gladstone Investment Corporation (NASDAQ:GAIN) is a business development company (BDC) specializing in investments in the lower middle market, focusing on mature-stage buyouts, refinancing existing debt, and various debt securities. The company avoids investing in startups, targeting instead small and mid-sized U.S. companies in manufacturing, consumer products, and business/consumer services. Gladstone typically invests between $5 million and $30 million in debt securities and $10 million to $40 million in equity, preferring companies with EBITDA ranging from $4 million to $15 million. They often seek minority equity stakes with a board seat, though they also take majority positions. Investments are generally held for seven years, with exits through sales, recapitalizations, IPOs, or third-party acquisitions.
Gladstone emphasizes stable cash flows and experienced management teams, often investing in industries with favorable growth prospects. Their due diligence process is rigorous, focusing on operational and financial stability, and they work closely with portfolio companies to drive growth and efficiency. This approach has positioned Gladstone as a reliable partner in the lower middle market, supporting companies through strategic initiatives and operational improvements.
3-Month Forecast: - Technical Outlook: GAIN is trading above its 20 and 50-day SMAs, indicating potential bullish momentum. The low ATR suggests controlled volatility, with support near $13.24 and resistance at $13.62. - Fundamental Outlook: A trailing P/E of 7.14 suggests undervaluation, while the forward P/E of 14.97 indicates expected growth. The P/B ratio of 1.04 reflects fair valuation relative to book value. A high P/S ratio may signal rich valuation, though a robust RoE of 14.29 underscores strong profitability. Overall, GAIN may offer attractive returns for investors seeking undervalued assets with growth potential.Additional Sources for GAIN Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
GAIN Stock Overview
Market Cap in USD | 438m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2005-06-23 |
GAIN Stock Ratings
Growth 5y | 78.8% |
Fundamental | -12.3% |
Dividend | 94.3% |
Rel. Strength | -9.81 |
Analysts | 3.4/5 |
Fair Price Momentum | 14.03 USD |
Fair Price DCF | - |
GAIN Dividends
Dividend Yield 12m | 13.41% |
Yield on Cost 5y | 30.24% |
Annual Growth 5y | 12.29% |
Payout Consistency | 94.6% |
GAIN Growth Ratios
Growth Correlation 3m | 42.3% |
Growth Correlation 12m | 66.6% |
Growth Correlation 5y | 88.4% |
CAGR 5y | 16.75% |
CAGR/Max DD 5y | 0.64 |
Sharpe Ratio 12m | -0.21 |
Alpha | -0.14 |
Beta | 1.281 |
Volatility | 18.54% |
Current Volume | 331.8k |
Average Volume 20d | 130.8k |
As of April 09, 2025, the stock is trading at USD 11.90 with a total of 331,830 shares traded.
Over the past week, the price has changed by -10.93%, over one month by -11.33%, over three months by -7.05% and over the past year by -3.28%.
Neither. Based on ValueRay Fundamental Analyses, Gladstone Investment is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.27 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GAIN as of April 2025 is 14.03. This means that GAIN is currently undervalued and has a potential upside of +17.9% (Margin of Safety).
Gladstone Investment has received a consensus analysts rating of 3.40. Therefor, it is recommend to hold GAIN.
- Strong Buy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, GAIN Gladstone Investment will be worth about 15.2 in April 2026. The stock is currently trading at 11.90. This means that the stock has a potential upside of +27.56%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 13.8 | 16% |
Analysts Target Price | 13.5 | 13.4% |
ValueRay Target Price | 15.2 | 27.6% |